Nurse Practitioner, Family · Miami, FL
NPI
1073996336
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1475 NW 12th Ave
Miami, FL, 33136
Phone (305) 243-4664
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
300 services
Medicare patients, 2024
161
Average age 74
Drug cost, 2024
$16.7M
1,796 prescriptions
Company payments, 2025
$21K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suzan Rosen was code 99214 (office e&m - established), 163 times for 96 patients. In total Suzan Rosen billed 300 services in 8 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 163 | 96 | $60.23 | $9,818 |
| 99214 Office E&M - Established | Office | 54 | 46 | $59.74 | $3,226 |
| 99215 Office E&M - Established | Facility | 40 | 23 | $102.84 | $4,114 |
| 99215 Office E&M - Established | Office | 13 | 13 | $98.49 | $1,280 |
| 86334 Immunoassay | Facility | 11 | 11 | $11.98 | $132 |
By year: 2022 $10K for 167 services; 2023 $17K for 255 services; 2024 $19K for 300 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86334 Immunoassay | 11 | 11 | $11.98 | $132 |
Medicare prescription drug claims, 2024
In 2024, the drug Suzan Rosen prescribed most often to Medicare patients was Acyclovir, with 410 prescriptions and refills. In total Suzan Rosen wrote 1,796 Medicare prescriptions that cost $16.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 410 | 714 | 104 | $5,336 |
| Pomalyst Pomalidomide | 323 | 323 | 50 | $7.4M |
| Revlimid Lenalidomide | 306 | 310 | 66 | $5.6M |
| Lenalidomide Generic | 165 | 165 | 41 | $2.1M |
| Xarelto Rivaroxaban | 84 | 120 | 15 | $67K |
| Venclexta Venetoclax | 65 | 65 | Under 11 | $870K |
| Gabapentin Generic | 42 | 44 | Under 11 | $279 |
| Colestipol Hcl Generic | 40 | 72 | 18 | $3,469 |
| Dexamethasone Generic | 40 | 64 | 22 | $595 |
| Ninlaro Ixazomib Citrate | 35 | 35 | Under 11 | $382K |
| Pantoprazole Sodium Generic | 24 | 47 | Under 11 | $284 |
| Ondansetron Odt Ondansetron | 22 | 29 | Under 11 | $294 |
| Alprazolam Generic | 22 | 22 | Under 11 | $122 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 31 | Under 11 | $120 |
| Ondansetron Hcl Generic | 18 | 18 | 13 | $165 |
Brand drugs: - claims; generic drugs: 942 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suzan Rosen $21K ($21K in general payments such as food, travel and fees) from 6 companies. The largest payer was Janssen Biotech, Inc. with $20K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.